ProPhase Labs Inc. (PRPH)
NASDAQ: PRPH
· Real-Time Price · USD
0.34
-0.02 (-5.03%)
At close: Jun 09, 2025, 3:59 PM
ProPhase Labs Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 6.77M | 12.75M | 17.97M | 28.71M | 44.38M | 62.71M | 78.54M | 94.42M | 122.65M | 145.98M | 131.25M | 111.3M | 79.04M | 39.05M | 33.42M | 27.9M |
Cost of Revenue | 6.92M | 16.88M | 19.61M | 23.43M | 28.14M | 32.13M | 38.32M | 41.92M | 51.99M | 71.17M | 64.43M | 58.74M | 46.23M | 19.81M | 17.11M | 14.78M |
Gross Profit | -150K | -4.13M | -1.64M | 5.29M | 16.24M | 30.58M | 40.22M | 52.5M | 70.65M | 74.81M | 66.82M | 52.56M | 32.81M | 19.24M | 16.3M | 13.12M |
Operating Income | -38.63M | -35.41M | -33.95M | -30.79M | -21.61M | -15.35M | -6.92M | 8.32M | 23.6M | 42.36M | 36.76M | 24.73M | 9.8M | -4.65M | -1.57M | -60K |
Interest Income | n/a | 39K | 40K | 67K | 78K | 69K | 93K | 91K | 153K | 234K | 439K | 628K | 642K | 540K | 349K | 146K |
Pretax Income | -42.33M | -38.03M | -35.72M | -32.2M | -22.8M | -16.32M | -7.76M | 7.56M | 22.91M | 37.72M | 31.96M | 20.16M | 5.3M | -5.33M | -1.93M | -460K |
Net Income | -53.36M | -27.76M | -26.31M | -23.6M | -16.78M | -10.47M | -4.37M | 6.52M | 18.46M | 31.5M | 26.55M | 17.71M | 6.27M | -5.29M | -1.72M | -259K |
Selling & General & Admin | 37.88M | 30.48M | 31.07M | 33.8M | 34.5M | 42.38M | 44.04M | 42.21M | 46.41M | 32.17M | 29.68M | 27.4M | 22.49M | 24.91M | 19.05M | 14.38M |
Research & Development | 594K | 807K | 1.11M | 1.55M | 1.42M | 1.62M | 1.3M | 760K | 651K | 277K | 375K | 440K | 520K | 868K | 717K | 689K |
Other Expenses | -18K | 124K | 91K | 99K | 1.32M | 41.11M | 41.15M | 49.24M | 47.97M | 17.2M | 16.91M | 8.8M | 10.13M | 7.62M | 7.88M | 8.91M |
Operating Expenses | 38.48M | 31.28M | 32.32M | 36.07M | 37.85M | 45.93M | 47.14M | 44.17M | 47.06M | 32.45M | 30.05M | 27.84M | 23.01M | 25.78M | 19.77M | 15.07M |
Interest Expense | 3.35M | 2.81M | 1.93M | 1.57M | 1.27M | 910K | 836K | 746K | 764K | 913K | 1.01M | 1.13M | 1.15M | 1.17M | 910K | 587K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.12M | -4.64M | -3.81M | n/a | 6.86M | 5.63M | 4.93M |
Cost & Expenses | 45.4M | 48.17M | 51.93M | 59.5M | 66M | 78.06M | 85.46M | 86.09M | 99.05M | 103.62M | 94.49M | 86.58M | 69.24M | 45.59M | 36.88M | 29.85M |
Income Tax Expense | 7.2M | -10.28M | -9.41M | -8.6M | -6.02M | -5.85M | -3.4M | 1.04M | 4.45M | 10.28M | 9.17M | 6.15M | 2.9M | -2.85M | -2.71M | -2.67M |
Shares Outstanding (Basic) | 20.46M | 19.08M | 18.89M | 18.05M | 18.05M | 17.18M | 16.84M | 16.75M | 16.21M | 20.25M | 18.77M | 18.4M | 15.44M | 15.3M | 15.15M | 14.56M |
Shares Outstanding (Diluted) | 20.46M | 19.08M | 18.89M | 18.05M | 18.05M | 17.18M | 16.84M | 18.06M | 16.21M | 20.25M | 19.27M | 18.74M | 15.44M | 15.44M | 15.15M | 18.2M |
EPS (Basic) | -2.83 | -1.51 | -1.46 | -1.33 | -0.94 | -0.61 | -0.27 | 0.33 | 0.98 | 1.82 | 1.51 | 1.02 | 0.41 | -0.37 | -0.14 | -0.04 |
EPS (Diluted) | -2.83 | -1.51 | -1.46 | -1.33 | -0.95 | -0.62 | -0.27 | 0.32 | 0.96 | 1.80 | 1.49 | 1.01 | 0.40 | -0.38 | -0.15 | -0.05 |
EBITDA | -32.34M | -27.25M | -26.43M | -23.5M | -14.83M | -9.64M | -1.69M | 13.41M | 28.73M | 45.32M | 39.31M | 26.93M | 11.39M | -1.98M | 218K | 781K |
EBIT | -38.98M | -35.22M | -33.79M | -30.62M | -21.52M | -15.41M | -6.93M | 8.31M | 23.67M | 38.63M | 32.97M | 21.29M | 6.45M | -4.16M | -1.04M | 100K |
Depreciation & Amortization | 6.64M | 7.97M | 7.37M | 7.12M | 6.7M | 5.78M | 5.23M | 5.11M | 5.06M | 6.69M | 6.33M | 5.65M | 4.93M | 2.5M | 1.58M | 997K |